Anat Ashkenazi
Finanzdirektor/CFO bei ELI LILLY AND COMPANY
Vermögen: 34 Mio $ am 30.04.2024
Profil
Anat Ashkenazi ist Mitglied des Vorstands von Varian Medical Systems, Inc. und Maravai Lifesciences Holdings, Inc. und Chief Financial Officer & Senior Vice President bei Eli Lilly & Co. Zuvor war Frau Ashkenazi Chief Financial Officer, Controller & Senior VP bei Lilly Research Laboratories. Anat Ashkenazi erhielt einen Bachelor-Abschluss von der Hebräischen Universität Jerusalem und einen MBA von der Universität Tel-Aviv.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ELI LILLY AND COMPANY
0,00% | 28.02.2024 | 42 521 ( 0,00% ) | 33 Mio $ | 30.04.2024 |
| 25.03.2024 | 40 123 ( 0,03% ) | 304 132 $ | 30.04.2024 |
Aktive Positionen von Anat Ashkenazi
| Unternehmen | Position | Beginn |
|---|---|---|
| ELI LILLY AND COMPANY | Finanzdirektor/CFO | 09.02.2021 |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Direktor/Vorstandsmitglied | 19.11.2020 |
Maravai Life Sciences, Inc.
 Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Anat Ashkenazi
| Unternehmen | Position | Ende |
|---|---|---|
| VARIAN MEDICAL SYSTEMS, INC. | Direktor/Vorstandsmitglied | 15.04.2021 |
| Lilly Diabetes | Finanzdirektor/CFO | - |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Finanzdirektor/CFO | - |
Ausbildung von Anat Ashkenazi
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Tel-Aviv University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Varian Medical Systems, Inc.
 Varian Medical Systems, Inc. Medical SpecialtiesHealth Technology Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical conditions. It operates through the Oncology Systems and Proton Solutions segments. The Oncology Systems segment designs, manufactures, sells, and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments. The Proton Solutions segment delivers proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer. The company was founded by William Hansen, Edward Ginzton, Russell Varian, and Sigurd Varian in 1948 and is headquartered in Palo Alto, CA. | Health Technology |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
Maravai Life Sciences, Inc.
Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Finance |
| Lilly Diabetes |
